Clinical Trials Directory

Trials / Completed

CompletedNCT01974245

Supplementation With Cholecalciferol in Dialysis Patients

Impact of Treatment With Cholecalciferol on Immunological Markers in Patients With Hypovitaminosis D on Dialysis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Federal University of São Paulo · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Hypovitaminosis D is highly prevalent among patients with chronic kidney disease, especially in those undergoing dialysis. The loss of protein to the dialysis solution seems to contribute significantly to the reduced serum levels of vitamin D in these patients. As a result of the disease and the dialysis procedure, there is high prevalence of chronic inflammation and high risk of infections. There is evidence in other populations, that vitamin D has immunomodulatory effects by stimulating the production of cathelicidin, an antimicrobial peptide and suppressing the production of proinflammatory cytokines. Thus, this study aims to investigate the effects of cholecalciferol supplementation on immunological markers in patients in hemodialysis and peritoneal dialysis with hypovitaminosis D . This is a randomized, double-blind, placebo-controlled trial in which patients who have vitamin D deficiency \[25 (OH) D \<20 ng / mL\] will be allocated to the intervention group (cholecalciferol) or control (placebo). Patients will receive supplemented 100,000 IU / week cholecalciferol a period of 12 weeks. Before and after the intervention will be determined 25(OH)D, cathelicidin, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and C-reactive protein serum. In monocytes, we will evaluate cathelicidin, IL-6 and TNF-α, 25(OH)D receptor and α 1-hydroxylase enzyme expression.

Conditions

Interventions

TypeNameDescription
DRUGCholecalciferol100,000 IU/week for 12 weeks
DRUGPlacebo100 drops/ week for 12 weeks

Timeline

Start date
2012-07-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2013-11-01
Last updated
2025-03-14
Results posted
2014-12-12

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01974245. Inclusion in this directory is not an endorsement.